These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 12445028)

  • 1. In vitro-in vivo correlations for drugs eliminated by glucuronidation: investigations with the model substrate zidovudine.
    Boase S; Miners JO
    Br J Clin Pharmacol; 2002 Nov; 54(5):493-503. PubMed ID: 12445028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered AZT (3'-azido-3'-deoxythymidine) glucuronidation kinetics in liver microsomes as an explanation for underprediction of in vivo clearance: comparison to hepatocytes and effect of incubation environment.
    Engtrakul JJ; Foti RS; Strelevitz TJ; Fisher MB
    Drug Metab Dispos; 2005 Nov; 33(11):1621-7. PubMed ID: 16049128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucuronidation of 3'-azido-3'-deoxythymidine (zidovudine) by human liver microsomes: relevance to clinical pharmacokinetic interactions with atovaquone, fluconazole, methadone, and valproic acid.
    Trapnell CB; Klecker RW; Jamis-Dow C; Collins JM
    Antimicrob Agents Chemother; 1998 Jul; 42(7):1592-6. PubMed ID: 9660989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenobarbital inducible UDP-glucuronosyltransferase is responsible for glucuronidation of 3'-azido-3'-deoxythymidine: characterization of the enzyme in human and rat liver microsomes.
    Haumont M; Magdalou J; Lafaurie C; Ziegler JM; Siest G; Colin JN
    Arch Biochem Biophys; 1990 Sep; 281(2):264-70. PubMed ID: 2118332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative prediction of in vivo inhibitory interactions involving glucuronidated drugs from in vitro data: the effect of fluconazole on zidovudine glucuronidation.
    Uchaipichat V; Winner LK; Mackenzie PI; Elliot DJ; Williams JA; Miners JO
    Br J Clin Pharmacol; 2006 Apr; 61(4):427-39. PubMed ID: 16542204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro glucuronidation of 3'-azido-3'-deoxythymidine by human liver. Role of UDP-glucuronosyltransferase 2 form.
    Rajaonarison JF; Lacarelle B; De Sousa G; Catalin J; Rahmani R
    Drug Metab Dispos; 1991; 19(4):809-15. PubMed ID: 1680659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Scaling factors for the in vitro-in vivo extrapolation (IV-IVE) of renal drug and xenobiotic glucuronidation clearance.
    Knights KM; Spencer SM; Fallon JK; Chau N; Smith PC; Miners JO
    Br J Clin Pharmacol; 2016 Jun; 81(6):1153-64. PubMed ID: 26808419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of 3'-azido-3'-deoxythymidine, morphine, and codeine as probe substrates for UDP-glucuronosyltransferase 2B7 (UGT2B7) in human liver microsomes: specificity and influence of the UGT2B7*2 polymorphism.
    Court MH; Krishnaswamy S; Hao Q; Duan SX; Patten CJ; Von Moltke LL; Greenblatt DJ
    Drug Metab Dispos; 2003 Sep; 31(9):1125-33. PubMed ID: 12920168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucuronidation of the antiretroviral drug efavirenz by UGT2B7 and an in vitro investigation of drug-drug interaction with zidovudine.
    Bélanger AS; Caron P; Harvey M; Zimmerman PA; Mehlotra RK; Guillemette C
    Drug Metab Dispos; 2009 Sep; 37(9):1793-6. PubMed ID: 19487252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of anticancer drugs on the glucuronidation of 3'-azido-3'-deoxythymidine in human liver microsomes.
    Rajaonarison JF; Lacarelle B; Catalin J; Durand A; Cano JP
    Drug Metab Dispos; 1993; 21(5):823-9. PubMed ID: 7902243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucuronidation of 3'-azido-3'-deoxythymidine: human and rat enzyme specificity.
    Resetar A; Spector T
    Biochem Pharmacol; 1989 May; 38(9):1389-93. PubMed ID: 2719717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of interaction between zidovudine and 4-methyl-amino-antipyrine, the active metabolite of metamizole, in human liver in vitro.
    Bacracheva N; Kamali F
    Methods Find Exp Clin Pharmacol; 1995 Jun; 17(5):299-301. PubMed ID: 8830197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucuronidation of 3'-azido-3'-deoxythymidine by rat and human liver microsomes.
    Cretton EM; Waterhous DV; Bevan R; Sommadossi JP
    Drug Metab Dispos; 1990; 18(3):369-72. PubMed ID: 1974201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucuronidation of 3'-azido-3'-deoxythymidine in human liver microsomes: enzyme inhibition by drugs and steroid hormones.
    Herber R; Magdalou J; Haumont M; Bidault R; van Es H; Siest G
    Biochim Biophys Acta; 1992 Jun; 1139(1-2):20-4. PubMed ID: 1610916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The glucuronidation of mycophenolic acid by human liver, kidney and jejunum microsomes.
    Bowalgaha K; Miners JO
    Br J Clin Pharmacol; 2001 Nov; 52(5):605-9. PubMed ID: 11736871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of inhibition potentials of drugs against zidovudine glucuronidation in rat hepatocytes and liver microsomes.
    Mano Y; Usui T; Kamimura H
    Drug Metab Dispos; 2007 Apr; 35(4):602-6. PubMed ID: 17267620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved Predictability of Hepatic Clearance with Optimal pH for Acyl-Glucuronidation in Liver Microsomes.
    Mizutare T; Sanoh S; Kanazu T; Ohta S; Kotake Y
    J Pharm Sci; 2022 Nov; 111(11):3165-3173. PubMed ID: 35995204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of various drugs on the glucuronidation of zidovudine (azidothymidine; AZT) by human liver microsomes.
    Sim SM; Back DJ; Breckenridge AM
    Br J Clin Pharmacol; 1991 Jul; 32(1):17-21. PubMed ID: 1909542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucuronidation of drugs by hepatic microsomes derived from healthy and cirrhotic human livers.
    Furlan V; Demirdjian S; Bourdon O; Magdalou J; Taburet AM
    J Pharmacol Exp Ther; 1999 May; 289(2):1169-75. PubMed ID: 10215701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Warfarin is an effective modifier of multiple UDP-glucuronosyltransferase enzymes: evaluation of its potential to alter the pharmacokinetics of zidovudine.
    Sun H; Zhang T; Wu Z; Wu B
    J Pharm Sci; 2015 Jan; 104(1):244-56. PubMed ID: 25393417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.